Photodynamic therapy-driven induction of suicide cytosine deaminase gene

Cancer Letters

Volumn 290, Issue 2, 2010, Pages 216-222

  Bil, Jacek ^a   Wlodarski, Pawel ^a   Winiarska, Magdalena ^a   Kurzaj, Zuzanna ^a   Issat, Tadeusz ^a   Jozkowicz, Alicja ^b   Wegiel, Barbara ^b   Dulak, Jozef ^b   Golab, Jakub ^a,c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c INSTITUTE OF PHYSICAL CHEMISTRY   (Poland)

Author keywords

5 Fluorocytosine; Cancer; Cytosine deaminase; Photodynamic therapy; Suicide gene therapy

Indexed keywords

CYTOSINE DEAMINASE; FLUCYTOSINE; FLUOROURACIL; HYPOXIA INDUCIBLE FACTOR; PHOSGENE; PHOTOFRIN; PLASMID VECTOR; PRODRUG;

ANIMAL CELL; ARTICLE; CANCER THERAPY; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY; GENE INDUCTION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HYPOXIA; MOLECULAR BEACON; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROMOTER REGION; SUICIDE GENE; TUMOR CELL;

ANIMALS; ANTIMETABOLITES; BLOTTING, WESTERN; CELL LINE, TUMOR; CYTOSINE DEAMINASE; FLUCYTOSINE; GENES, TRANSGENIC, SUICIDE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICE; PHOTOCHEMOTHERAPY; PRODRUGS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77649190204     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2009.09.012     Document Type: Article

References (29)

1. Dougherty T.J., Gomer C.J., Henderson B.W., Jori G., Kessel D., Korbelik M., Moan J., and Peng Q. Photodynamic therapy. J. Natl. Cancer Inst. 90 (1998) 889-905
2. Tromberg B.J., Orenstein A., Kimel S., Barker S.J., Hyatt J., Nelson J.S., and Berns M.W. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem. Photobiol. 52 (1990) 375-385
3. Zilberstein J., Bromberg A., Frantz A., Rosenbach-Belkin V., Kritzmann A., Pfefermann R., Salomon Y., and Scherz A. Light-dependent oxygen consumption in bacteriochlorophyll-serine-treated melanoma tumors: on-line determination using a tissue-inserted oxygen microsensor. Photochem. Photobiol. 65 (1997) 1012-1019
4. Fingar V.H., Wieman T.J., Wiehle S.A., and Cerrito P.B. The role of microvascular damage in photodynamic therapy: the effect of treatment on vessel constriction permeability, and leukocyte adhesion. Cancer Res. 52 (1992) 4914-4921
5. Reed M.W., Miller F.N., Wieman T.J., Tseng M.T., and Pietsch C.G. The effect of photodynamic therapy on the microcirculation. J. Surg. Res. 45 (1988) 452-459
6. Henderson B.W., Owczarczak B., Sweeney J., and Gessner T. Effects of photodynamic treatment of platelets or endothelial cells in vitro on platelet aggregation. Photochem. Photobiol. 56 (1992) 513-521
7. Vaupel P., and Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metast. Rev. 26 (2007) 225-239
8. Hockel M., and Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J. Natl. Cancer Inst. 93 (2001) 266-276
9. Zagorska A., and Dulak J. HIF-1: the knowns and unknowns of hypoxia sensing. Acta Biochim. Pol. 51 (2004) 563-585
10. Weidemann A., and Johnson R.S. Biology of HIF-1α. Cell Death Differ. 15 (2008) 621-627
11. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
12. Ferrario A., von Tiehl K.F., Rucker N., Schwarz M.A., Gill P.S., and Gomer C.J. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma. Cancer Res. 60 (2000) 4066-4069
13. Mitra S., Cassar S.E., Niles D.J., Puskas J.A., Frelinger J.G., and Foster T.H. Photodynamic therapy mediates the oxygen-independent activation of hypoxia-inducible factor 1α. Mol. Cancer Ther. 5 (2006) 3268-3274
14. Ji Z., Yang G., Shahzidi S., Tkacz-Stachowska K., Suo Z., Nesland J.M., and Peng Q. Induction of hypoxia-inducible factor-1α overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy. Cancer Lett. 244 (2006) 182-189
15. Koukourakis M.I., Giatromanolaki A., Skarlatos J., Corti L., Blandamura S., Piazza M., Gatter K.C., and Harris A.L. Hypoxia inducible factor (HIF-1α and HIF-2α) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy. Cancer Res. 61 (2001) 1830-1832
16. Dong D., Dubeau L., Bading J., Nguyen K., Luna M., Yu H., Gazit-Bornstein G., Gordon E.M., Gomer C., Hall F.L., Gambhir S.S., and Lee A.S. Spontaneous and controllable activation of suicide gene expression driven by the stress-inducible grp78 promoter resulting in eradication of sizable human tumors. Human Gene Ther. 15 (2004) 553-561
17. Luna M.C., Chen X., Wong S., Tsui J., Rucker N., Lee A.S., and Gomer C.J. Enhanced photodynamic therapy efficacy with inducible suicide gene therapy controlled by the grp promoter. Cancer Res. 62 (2002) 1458-1461
18. Huber B.E., Austin E.A., Good S.S., Knick V.C., Tibbels S., and Richards C.A. In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53 (1993) 4619-4626
19. Szokalska A., Makowski M., Nowis D., Wilczynski G.M., Kujawa M., Wojcik C., Mlynarczuk-Bialy I., Salwa P., Bil J., Janowska S., Agostinis P., Verfaillie T., Bugajski M., Gietka J., Issat T., Glodkowska E., Mrowka P., Stoklosa T., Hamblin M.R., Mroz P., Jakobisiak M., and Golab J. Proteasome inhibition potentiates antitumor effects of photodynamic therapy in mice through induction of endoplasmic reticulum stress and unfolded protein response. Cancer Res. 69 (2009) 4235-4243
20. Powers W.E., and Tolmach L.J. Demonstration of an anoxic component in a mouse tumor-cell population by in vivo assay of survival following irradiation. Radiology 83 (1964) 328-336
21. Dewhirst M.W., Cao Y., and Moeller B. Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat. Rev. Cancer 8 (2008) 425-437
22. Stanley J.A., Shipley W.U., and Steel G.G. Influence of tumour size on hypoxic fraction and therapeutic sensitivity of Lewis lung tumour. Brit. J. Cancer 36 (1977) 105-113
23. Tredan O., Galmarini C.M., Patel K., and Tannock I.F. Drug resistance and the solid tumor microenvironment. J. Natl. Cancer Inst. 99 (2007) 1441-1454
24. Henderson B.W., and Fingar V.H. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res. 47 (1987) 3110-3114
25. Golab J., Olszewska D., Mroz P., Kozar K., Kaminski R., Jalili A., and Jakobisiak M. Erythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy-induced anemia. Clin. Cancer Res. 8 (2002) 1265-1270
26. White L., Gomer C.J., Doiron D.R., and Szirth B.C. Ineffective photodynamic therapy (PDT) in a poorly vascularized xenograft model. Brit. J. Cancer 57 (1988) 455-458
27. Foster T.H., Murant R.S., Bryant R.G., Knox R.S., Gibson S.L., and Hilf R. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat. Res. 126 (1991) 296-303
28. Klimova T., and Chandel N.S. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ. 15 (2008) 660-666
29. Pierrefite-Carle V., Baque P., Gavelli A., Mala M., Chazal M., Gugenheim J., Bourgeon A., Milano G., Staccini P., and Rossi B. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect. J. Natl. Cancer Inst. 91 (1999) 2014-2019